Table 5 |
||||||
|
Multiple infection (MI) rates from the total data set and various subsamples. |
||||||
|
Sample or Subsample |
Observed or Expected Number of MI |
Observed or Expected Incidence of MI |
Incidence of MI from other study |
Sample Size Other Study |
p-value |
Refer-ence Other Study |
|
|
||||||
|
All data |
23.00 |
0.40 |
0.143 |
7 |
0.2293 |
[9] |
|
pol data only |
12 |
0.21 |
0.078 |
64 |
0.0431 |
[12] |
|
env data only |
12 |
0.21 |
||||
|
2 visits per subject |
19.92 |
0.34 |
||||
|
2 visits per subject; env data only |
10.67 |
0.18 |
||||
|
2 visits per subject; pol data only |
9.75 |
0.17 |
||||
|
2 visits per subject; env data only; 10 sequences per subject |
8.14 |
0.14 |
0.000 |
37 |
0.0031 |
[14] |
|
1 visit per subject |
8.83 |
0.15 |
||||
|
1 visit per subject; env data only |
3.58 |
0.06 |
0.013 |
147 |
0.0793 |
[10] |
|
1 visit per subject; pol data only |
5.25 |
0.09 |
||||
|
1 visit per subject; pol data only; 2.5 sequences per subject |
3.60 |
0.06 |
||||
|
1 visit per subject; pol data only; 2.5 sequences per subject; assume no intergenic recombination |
0.16 |
0.00 |
0.000 |
718 |
0.2563 |
[11] |
|
|
||||||
|
Templeton et al. Retrovirology 2009 6:54 doi:10.1186/1742-4690-6-54 |
||||||